NYSE:ABTMedical Equipment
Abbott CEO Share Purchase Highlights $21b Exact Sciences Deal And Valuation
Abbott Laboratories (NYSE:ABT) CEO Robert Ford bought company shares after the latest earnings release and investor reaction.
The purchase followed Abbott's announcement of a planned US$21b acquisition of cancer diagnostics firm Exact Sciences.
The combination of a large deal and a CEO share purchase has drawn attention from shareholders watching management’s alignment with the business.
Abbott Laboratories operates across medical devices, diagnostics, nutrition, and branded generic...